Assaying fibroblast activation protein (FAP) expression <i>in vivo</i> and <i>in vitro</i> for possible targeting with chimeric antigen receptor (CAR) T cells
Pedro O. Méndez Fernández(California Institute for Regenerative Medicine), Jonathan A. Epstein(University of Pennsylvania), Joel G. Rurik(Karolinska Institutet), Haig Aghajanian(Therapeutics Clinical Research)
Cited by 0
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|799
Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force
|Genetics in Medicine|2002|398
Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes.
|Journal of Biological Chemistry|1994|366